V. Harvey

Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)

Stephen Chia, Tamas Hickish, V. Harvey et al. · Annals of Oncology · 2013 · 1.3K citations

Medicine, Oncology, Pharmacology +14

A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-up.

John A. Levi, Damien Thomson, T Sandeman et al. · Journal of Clinical Oncology · 1988 · 66 citations

Medicine, Oncology, Surgery +16

Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer

M. D. Green, Prudence A. Francis, Val Gebski et al. · Annals of Oncology · 2009 · 63 citations · Full text

Medicine, Oncology, Pharmacology +12

A randomized trial of capecitabine (C) given intermittently (IC) rather than continuously (CC) compared to classical CMF as first-line chemotherapy for advanced breast cancer (ABC)

Martin R. Stockler, T. Sourjina, Peter Grimison et al. · Journal of Clinical Oncology · 2007 · 59 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

S5-6: Neoadjuvant Pertuzumab and Trastuzumab Concurrent or Sequential with an Anthracycline-Containing or Concurrent with an Anthracycline-Free Standard Regimen: A Randomized Phase II Study (TRYPHAENA).

S. Chia, Tamas Hickish, V. Harvey et al. · Cancer Research · 2011 · 57 citations

Medicine, Oncology, Pharmacology +17